1500 E Medical Center Dr
Ann Arbor, MI 48109
Available to mentor
Dr. Yolanda Helfrich is a Professor of Dermatology and the residency program director of the Department of Dermatology at the University of Michigan Medical School. She serves as Chief of Medical Dermatology and provides medical dermatology services to patients of all ages within in our medical dermatology outpatient clinics.
Dr. Helfrich’s primary clinical focus is on medical dermatology. She has a special interest in rosacea, and has been invited to speak and write nationally about the pathogenesis and treatment of rosacea. She serves on the National Rosacea Society Medical Advisory Board. She also has a clinical specialization in the follow-up and diagnosis of high-risk skin cancer patients and runs a specialty clinic devoted to the care of patients with alopecia (hair loss).
Dr. Helfrich is a Michigan native. She grew up in Grayling and attended Grayling High School. She graduated with a B.A. in Latin and Ancient History from Swarthmore College in Pennsylvania. She subsequently attended medical school at the University of Michigan Medical School, graduating in 2001. Dr. Helfrich completed her internship in internal medicine and her residency in dermatology at the University of Michigan. She joined the faculty at the University of Michigan Department of Dermatology in 2005
-
Center MemberSamuel and Jean Frankel Cardiovascular Center
Throughout her career, Dr. Helfrich has had a strong interest in clinical research, and served as the Director of the Program for Clinical Research in Dermatology (PCRiD) in the department for 12 years. She has served as Primary Investigator on over 25 departmental and industry-sponsored clinical trials and research investigations of rosacea, atopic dermatitis, psoriasis, lichen planus, and other dermatologic conditions. She served on the Michigan Medicine Research Board of Directors Clinical Trials Subcommittee, with the key task of helping the institution create a unified clinical research enterprise, and subsequently served as one of the inaugural Medical Directors of the Neurosciences and Sensory Clinical Trials Support Unit.
-
Helfrich Y. 2024 Nov 15;PresentationPlenary Session I: Leadership Development: Key Leadership Skills for Trainees
-
Nelson JM, Rizzo JM, Greene RK, Fahlstrom K, Troost JP, Helfrich YR, Nakamura M. Cureus, 2024 Oct; 16 (10): e72363Journal ArticleEvaluation of Helicobacter pylori and Small Intestinal Bacterial Overgrowth in Subjects With Rosacea.
DOI:10.7759/cureus.72363 PMID: 39583431 -
Helfrich Y. 2024 Sep 25;PresentationThe red face: when it's not rosacea
-
Weinberg L, Pazhyanur S, Helfrich Y. Journal of the American Academy of Dermatology, 2024 Sep; 91 (3): ab54Journal Article51469 Increasing access to dermatologic care for uninsured patients via teledermatology at a student-run free clinic in Michigan
DOI:10.1016/j.jaad.2024.07.224 -
Dirr MA, Ahmed A, Schlessinger DI, Haq M, Shi V, Koza E, Ma M, Christensen RE, Ibrahim SA, Schmitt J, Johannsen L, Asai Y, Baldwin HE, Berardesca E, Berman B, Vieira AC, Chien AL, Cohen DE, Del Rosso JQ, Dosal J, Drake LA, Feldman SR, Fleischer AB, Friedman A, Graber E, Harper JC, Helfrich YR, Jemec GB, Johnson SM, Katta R, Lio P, Maier LE, Martin G, Nagler AR, Neuhaus IM, Palamar M, Parish LC, Rosen T, Shumack SP, Solomon JA, Tanghetti EA, Webster GF, Weinkle A, Weiss JS, Wladis EJ, Maher IA, Sobanko JF, Cartee TV, Cahn BA, Alam M, IMPROVED-COS Rosacea Working Group , Kang BY, Iyengar S, Anvery N, Alpsoy E, Bewley A, Dessinioti C, Egeberg A, Engin B, Gollnick HPM, Ioannides D, Kim HS, Lazaridou E, Li J, Lim HG, Micali G, de Oliveira CMM, Noguera-Morel L, Parodi A, Reinholz M, Suh DH, Sun Q, van Zuuren EJ, Wollina U, Zhou Y, Zip C, Poon E, Pearlman R. JAMA Dermatol, 2024 Jun 1; 160 (6): 658 - 666.Journal ArticleRosacea Core Domain Set for Clinical Trials and Practice: A Consensus Statement.
DOI:10.1001/jamadermatol.2024.0636 PMID: 38656294 -
Tang M, Ratycz M, Helfrich YR. JAAD Case Reports, 2024 May;Journal ArticleDermatoscopy case of the month: Erythromelanosis follicularis faciei et colli
DOI:10.1016/j.jdcr.2024.05.014 -
Shao S, Sun Z, Chu M, Chen J, Cao T, Swindell WR, Bai Y, Li Q, Ma J, Zhu Z, Schuler A, Helfrich Y, Billi AC, Li Z, Hao J, Xiao C, Dang E, Gudjonsson JE, Wang G. Br J Dermatol, 2024 Mar 15; 190 (4): 536 - 548.Journal ArticleFormylpeptide receptor 1 contributes to epidermal barrier dysfunction-induced skin inflammation through NOD-like receptor C4-dependent keratinocyte activation.
DOI:10.1093/bjd/ljad455 PMID: 37979162 -
Lamberg O, Abdel-Mageed S, Olsen E, Guerrero G, Helfrich YR, Mervak JE. Arch Dermatol Res, 2024 Feb 24; 316 (3): 92Journal ArticlePatient perspectives on topical minoxidil for hair loss: a survey-based study from the University of Michigan Alopecia Clinic.
DOI:10.1007/s00403-024-02820-9 PMID: 38400906
